LUCY vs CLPS

For growth investors, Innovative Eyewear, Inc.

(LUCY) is the stronger pick with 42. 0% revenue growth year-over-year, versus 15. 2% for CLPS Incorporation (CLPS). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, CLPS Incorporation (CLPS) delivered a total return of -69.

3%, compared to -99. 1% for Innovative Eyewear, Inc. (LUCY). Over 10 years, the gap is even starker: CLPS returned -78. 5% versus LUCY's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CLPS Incorporation (CLPS) is the lower-risk stock at 0.

27β versus Innovative Eyewear, Inc. 's 1. 52β — meaning LUCY is approximately 459% more volatile than CLPS relative to the S&P 500.

By revenue growth (latest reported year), Innovative Eyewear, Inc.

(LUCY) is pulling ahead at 42. 0% versus 15. 2% for CLPS Incorporation (CLPS). On earnings-per-share growth, the picture is similar: Innovative Eyewear, Inc. grew EPS 59. 0% year-over-year, compared to -181. 4% for CLPS Incorporation. Over a 3-year CAGR, LUCY leads at 33. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CLPS Incorporation (CLPS) is the more profitable company, earning -4.

3% net margin versus -474. 6% for Innovative Eyewear, Inc. — meaning it keeps -4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLPS leads at -4. 0% versus -484. 2% for LUCY. At the gross margin level — before operating expenses — CLPS leads at 20. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, CLPS (14.

6% yield) pays a dividend. LUCY does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CLPS Incorporation (CLPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

27), 14. 6% yield). Innovative Eyewear, Inc. (LUCY) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLPS: -78. 5%, LUCY: -99. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (LUCY (Healthcare) and CLPS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

CLPS pays a dividend while LUCY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.